Recombinant fraction 1 protein of Yersinia pestis activates murine peritoneal macrophages in vitro

Cellular Immunology

Volumn 229, Issue 1, 2004, Pages 52-61

  Sodhi, Ajit ^a   Sharma, Rajesh Kumar ^a   Batra, H V ^b   Tuteja, Urmil ^b  

^a BANARAS HINDU UNIVERSITY   (India)

^b DEFENCE RESEARCH AND DEVELOPMENT ESTABLISHMENT   (India)

Author keywords

Chemokines; IL 1; IL 6; Macrophages; NO; rF1 antigen; TNF ; Toll like receptor; Yersinia pestis

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; BACTERIAL PROTEIN; CHEMOKINE; GAMMA INTERFERON; GENISTEIN; INTERLEUKIN 1; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; RANTES; RECOMBINANT FRACTION 1 PROTEIN; RECOMBINANT PROTEIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; WORTMANNIN;

ANIMAL CELL; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION; YERSINIA PESTIS;

ANIMALS; FEMALE; INTERLEUKIN-1; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED A; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RECOMBINANT PROTEINS; RIBULOSE-BISPHOSPHATE CARBOXYLASE; TUMOR NECROSIS FACTOR-ALPHA; YERSINIA PESTIS;

MURINAE; YERSINIA; YERSINIA PESTIS;

EID: 4344677276     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellimm.2004.05.003     Document Type: Article

References (41)

1. Cornelis G.R., Boland A., Boyd A.P., Geuijen C., Iriarte M., Neyt C., Sory M.-P., Stainier I. The virulence plasmid of Yersinia, an antihost genome. Microbiol. Mol. Rev. 62:1998;1315-1352
2. Hanski C., Kutschka U., Schmoranzer H.P., Naumann M., Stallmach A., Hahn H., Menge H., Riecken E.O. Immunohistochemical and electron microscopic study of interaction of Yersinia enterocolitica serotype O8 with intestinal mucosa during experimental enteritis. Infect. Immun. 57:1989;673-678
3. Simonet M., Richard S., Berche P. Electron microscopic evidence for in vivo extracellular localization of Yersinia pseudotuberculosis harboring the pYV-plasmid. Infect. Immun. 58:1990;841-845
4. Cornelis G.R. How Yops find their way out of Yersinia. Mol. Microbiol. 50:2003;1091-1094
5. Straley S.C., Skrzypek E., Plano G.V., Bliska J.B. Yops of Yersinia spp. pathogenic for humans. Infect. Immun. 61:1993;3105-3110
6. Forsberg A., Rosqvist R., Wolf-Watz H. Regulation and polarized transfer of the Yersinia outer proteins (Yops) involved in antiphagocytosis. Trends Microbiol. 2:1994;14-19
7. Muller S., Feldman M.F., Cornelis G.R. The Type III secretion system of Gram-negative bacteria: a potential therapeutic target? Exp. Opin. Ther. Targets. 5:2001;327-339
8. Ferber D.M., Brubaker R.R. Plasmids in Yersinia pestis. Infect. Immun. 31:1981;839-841
9. Protsenko O.A., Anisimov P.I., Mosarov O.T., Donnov N.P., Popov Y.A., Kokushkin A.M. Detection and characterization of Yersinia pestis plasmids determining pesticin 1 fraction 1 antigen and mouse toxin synthesis. Genetica. 19:1983;1081-1090
10. Cherepanov P.A., Mikhailova T.G., Karimova G.A., Zakharova N.M., Ershov Y., Volvoi K.I. Clonning and detailed mapping of the pFra-ymt region of the Yersinia pestis plasmid pFra. Mol. Gen. Mikrobiol. Virusol. 12:1991;19-26
11. Brown S.D., Montie T.C. Beta-adrenergic blocking activity of Yersinia pestis murine toxin. Infect. Immun. 18:1977;85-93
12. Brubaker R.R. Factors promoting acute and chronic disease caused by yersiniae. Clin. Microbiol. Rev. 4:1991;309-324
13. Burrows T.W. Virulence of Pasteurella pestis and immunity to plague. Ergebn. Mikrobiol. 37:1963;59-113
14. Galyov E.E., Oyu Smirnov, Karlishev A.V., Volvoi K.I., Denesyuk A.I., Nazimov I.V., Rubtsov K.S., Abramov V.M., Dalvadyanz S.M., Zavyalov V.P. Nucleotide sequence of the Yersinia pestis gene encoding F1 antigen and the primary structure of the protein: putative T cell and B cell epitopes. FEBS Lett. 277:1990;230-232
15. Galyov E.E., Karlishev A.V., Chernovskaya T.V., Dolgikh D.A., Oyu Smirnov, Volvoi K.I., Abramov V.M., Zavyalov V.P. Expression of the envelope antigen F1 of Yersinia pestis is mediated by the product of the Caf1M gene having homology with the chaperon protein Pap D of Escherichia coli. FEBS Lett. 286:1991;79-82
16. Karlishev A.V., Galyov E.E., Oyu Smirnov, gazayev A.P., Abramov V.M., Zavyalov V.P. A new gene of the f1 operon of Y. pestis is involved in the capsule biogenesis. FEBS Lett. 297:1992;77-80
17. Sabhnani L., Rao D.N. Identification of immunodominant epitope of F1 antigen of Yersinia pestis. FEMS Immunol. Med. microbiol. 27:2002;155-162
18. Grebtsova N.N., Cherniavskaia A.S., Lebedeva S.A., Ivanova V.S. The phagocytic activity of peritoneal macrophages in relation to Yersinia pestis with defective and complete Fra genes. Zh. Mikrobiol. Epidemiol. Immunobiol. 5:1990;7-11
19. Isupov I.V., Nazarova L.S., Pavlova L.P., Gor'kova A.V., Revazova E.S., Dushkin V.A., Siu Zadumina, Surikov N.N., Taranenko T.M., Dzhaparidze M.N., et al. The effect of different Yersinia pestis antigens on the cellular link in immunity. Zh. Mikrobiol. Epidemiol. Immunobiol. 9:1990;85-89
20. Vasilleva G.I., Deroshenko E.P., Kiseleva A.K. Changes in the "latent" virulence of a vaccinal strain of Yersinia pestis multiplying within macrophages. Zh. Mikrobiol. Epidemiol. Immunobiol. 9:1988;63-66
21. Adams D.O., Hamilton T.A. Gallin J.I., Goldstein I.M., Snyderman R. Inflammation Basic Principles and Clinical Correlates. second ed.:1992;637-662 Raven Press, New York
22. Germain R.N., Margulies D.H. The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 11:1993;403-450
23. Sodhi A., Singh R.K., Singh S.M. Effect of IFN-γ priming of murine peritoneal macrophages on the activation of tumoricidal state by IL-1, TNF and cisplatin. Clin. Exp. Immunol. 888:1992;350-355
24. Agrawal S., Agrawal A., Doughty B., Gerwitz A., Blenis J., Dyke T.V., Pulendran B. Cutting edge: different toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J. Immunol. 171:2003;4984-4989
25. Mathews N., Neal M.L. Cytotoxicity assay for tumor necrosis factor and lymphotoxin. Clemens M.J., Morris A.G., Gearing A.J.H. Lymphokines and Interferons. 1987;221-226 IRL Press, Oxford
26. Mizel S.B. Interleukin and T-cell activation. Immunol. Rev. 63:1982;51-72
27. Sharma R.K., Sodhi A., Batra H.V., Tuteja U. Effect of rLcrV and rYopB from Yersinia pestis on murine peritoneal macrophages in vitro. Immunol. Lett. 93:2004;179-187
28. Drapier J.C., Wietzerbin J., Hibbs J.B. Jr. Interferon-γ and Tumor necrosis factor induce the L-arginine-dependant cytotoxic effector mechanism in murine macrophages. Eur. J. Immunol. 18:1988;1587-1592
29. Stuehr D.J., Marletta M.A. Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines or Interferon-γ J. Immunol. 139:1987;518-525
30. Stuehr D.J., Cho H.J., Kwon N.S., Weise M.F., Nathan C.F. Purification and characterization of cytokine-induced marophagen nitric oxide synthase: an FAD and FMN-containing flavoprotein. Proc. Natl. Acad. Sci. USA. 88:1991;7773-7777
31. Pellat H.Y., Drapier J.C. IFN-activated macrophage detection by electron paramagnetic resonance of complex between L-arginine-derived NO and non-heme iron proteins. Biochem. Biophys. Res. Commun. 166:1990;119-127
32. Ranjan P., Sodhi A., Srivastawa A. Cisplatin and interferon-γ treated murine macrophages induces apoptosis in tumor cell lines. Anti-Cancer Drugs. 8:1997;1-10
33. Kurose I., Hugichi H., Yonei Y., Ebinuma H., Watanabe N., Hokari R., Fukumura D., Miura S., Takaishi M., Saito H., Nakatsumi R.C., Ishii H. Rat kuffer cell-derived nitric oxide suppresses proliferation and induces apoptosis of syngeneic hepatoma cells. Gastroenterology. 11:1996;1058-1070
34. Wong G.G., Clark S.C. Multiple actions of interleukin 6 within a cytokine network. Immunol. Today. 9:1988;137-139
35. Hamilton T.A., Tannenbaem C.S., Finke J., Bukowski R. Interactions between chemokines and other cytokines in host response to tumor. Rollins B.J. Chemokines and Cancer. 1999;115-126 Humana Press Inc, Totowa, NJ
36. Hamilton T.A. Molecular basis of macrophage activation: from gene expression to phenotypic diversity. Burke B., Lewis C.E. The Macrophage. second ed.:2002;1-61 Oxford University Press, Oxford, UK
37. Wang C., Deng L., Hong M., Akkaraju G.R., Inoue J., Chen Z.J. TAK 1 is a ubiquitin-dependent kinase of MKK and IKK. Nature. 412:2001;346-351
38. Zhang J., Xu K., Ambati B., Yu F.S. Toll-like receptor 5-mediated corneal epithelial inflammatory responses to Pseudomonas aeruginosa flagellin. Invest. Ophthalmol. Vis. Sci. 44:2003;4247-4254
39. Way S.S., Thompson L.J., Lopes J.E., Hajjar A.M., Kollmann T.R., Freitag N.E., Wilson C.B. Characterization of flagellin expression and its role in Listeria monocytogenes infection and immunity. Cell. Microbiol. 6:2004;235-242
40. Mizel S.B., West A.P., Hantgan R.R. Identification of a sequence in human toll-like receptor 5 required for the binding of Gram-negative flagellin. J. Biol. Chem. 278:2003;23624-23629
41. Jacchieri S.G., Torquato R., Brentani R.R. Structural study of binding of flagellin by Toll-like receptor 5. J. Bacteriol. 185:2003;4243-4247